ReeToo is an innovative China-based in vitro diagnostics company.
Investment highlights
2017
Year of establishment
China
Country
2021
Year of entry
4.36%
Shareholding percentage
Healthcare and life sciences
Sector
ReeToo is an innovative China-based in vitro diagnostics company which develops and manufactures fully automated diagnostic solutions which are integrated with the company’s proprietary AI technology for cell morphological analysis. The company’s major product lines include diagnostic equipment and consumables for samples including leucorrhea, blood cells and chromosomes.
Sofina invested in ReeToo in 2021. The company is also backed by LYFE Capital.